Medline stock debuts at $29: what investors should watch after IPO

Medline stock made a blockbuster debut on Wednesday with its IPO listing at $29 per share. The company raised roughly $6.26 billion and hit the public markets with an implied valuation near $50 billion, making it the year's biggest listing. The Northfield, Illinois-based medical-supplies giant, backed by Blackstone, Carlyle, and Hellman & Friedman, upsized the deal to meet robust institutional demand. Opening trades suggested the stock could gap higher on day one. But investors need to focus on some critica ...